Liraglutide – Next-Generation Antidiabetic Medication, No Country

Print

Novo Nordisk’s NovoMix 30 is a unique insulin analogue that combines rapid and intermediate acting insulin aspart, providing the insulin requirement in a single injection.
 
«Back | Next»




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development